Results 181 to 190 of about 235,111 (295)

Overall outcome, functioning, and disability in older adults 3 to 14 years after traumatic brain injury

PM&R, EarlyView.
Abstract Background Epidemiological studies show an increasing incidence of traumatic brain injury (TBI) among people aged 65 years and older. Advances in neurointensive care have improved survival after TBI. There is a need for knowledge about long‐term outcome after TBI among older survivors of TBI.
Charlotta von Seth, Anders Lewén, Marianne Lannsjö, Per Enblad, Jan Lexell   +4 more
wiley   +1 more source

Early Anticoagulation in Large Volume Cardioembolic Stroke: Rethinking the Optimal Initiation Time. [PDF]

J Clin Neurol
Kwon HS, Koh SH.
europepmc   +1 more source

Population Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular Events

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Asundexian is a potent, selective, and reversible inhibitor of activated clotting Factor XI currently under development for secondary prevention of recurrent ischemic stroke in the ongoing Phase III OCEANIC‐STROKE study (NCT05686070). Here, we report the development of a population pharmacokinetic (popPK) model for asundexian.
Ashraf Yassen, Friederike Kanefendt, Jochen Zisowsky, Astrid Broeker, Hardi Mundl, Peter Vis, Dirk Garmann, Jan Berkhout   +7 more
wiley   +1 more source

Impact of Anticoagulation Therapy on Healthcare Utilization in Patients With Epistaxis. [PDF]

Laryngoscope Investig Otolaryngol
Andersen B, Kadrie A, Chanamolu M, Gillespie MB.   +3 more
europepmc   +1 more source

Adherence to anticoagulation management practices.

, 2016
Charlène Insam, Méan Marie, Andreas Limacher, Angelillo-Scherrer Anne, Aschwanden Markus, Martin Banyai, Hans Beer Juerg, Bounameaux Henri, Michael Egloff, Frauchiger Beat, Husmann Marc, Kucher Nils, Lämmle Bernhard, Matter Christian, Osterwalder Joseph, Righini Marc, Daniel Staub, Rodondi Nicolas, Aujesky Drahomir   +18 more
openalex   +2 more sources

Identification of Clinically Distinct Clusters in Patients With Severe COPD Using Circulating Blood Cell Population Parameters

Respirology, EarlyView.
This study investigated whether blood cell population data, in addition to cell counts, can identify clinically relevant COPD subgroups. Four distinct inflammatory profiles were identified with distinct clinical characteristics. Cell population data have the potential to provide additional insights beyond inflammatory cell counts and improve patient ...
Pauline J. M. Kuks, Jorine E. Hartman, Else A. M. D. ter Haar, L. Joost van Pelt, Dirk‐Jan Slebos, Maarten van den Berge, Simon D. Pouwels   +6 more
wiley   +1 more source

Restarting anticoagulation early versus late in patients with chronic subdural hematoma and atrial fibrillation (RELACS): a phase III international multicenter, randomized controlled, two-arm, assessor-blinded trial. [PDF]

Trials
Raj R, Tommiska P, Kivisaari R, Korja M, Luostarinen T, Virta JJ, Taimela S, Järvinen TLN, Niemelä M, Koivisto T, Leinonen V, Saemundsson B, Fletcher-Sandersjöö A, Korhonen T, Tetri S, Rauhala M, Laukka D, Czuba T, Bartek J, Danner N, Knuutinen O, Luoto T, Posti JP, Satopää J.   +23 more
europepmc   +1 more source

A new era in anticoagulation

, 2015
Danielle Barron
openalex   +1 more source

The Challenges of Vascular Implants: Regulatory Strategies and Biological Responses

Small Science, EarlyView.
Implantable vascular devices are revolutionizing the management of cardiovascular diseases, such as heart failure, by enabling real‐time monitoring and individualized therapy. However, their potential is challenged by regulatory constraints and biological barriers, as device implantation into a vessel can trigger inflammation, thrombosis, and long‐term
Serena Babboni, Rosa Sicari, Lara Russo, Virgilio Mattoli, Giuseppina Basta, Serena Del Turco   +5 more
wiley   +1 more source

Chronic anticoagulation therapy associated with increased complications following hemiarthroplasty in hip fracture patients. [PDF]

Eur J Orthop Surg Traumatol
Shabani S, Wier J, Mulakaluri A, McCavitt D, Duong A, Firoozabadi R, Patterson J.   +6 more
europepmc   +1 more source